RESEARCHER PROFILE

Hussein Hallak

← Back to Al-Quds University

H

Al-Quds University

Pharmacogenetics and Drug MetabolismPharmacy and Medical PracticesNitric Oxide and Endothelin EffectsSynthesis and biological activityCholinesterase and Neurodegenerative Diseases

Hussein Hallak works in Pharmacogenetics and Drug Metabolism, Pharmacy and Medical Practices, Nitric Oxide and Endothelin Effects, Synthesis and biological activity, Cholinesterase and Neurodegenerative Diseases. Recorded institutional associations include Al-Quds University.

104Publications
2,691Citations
28H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure

    1999 · 323 citations
  2. Matrix Metalloproteinase Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in a Rat Model of Progressive Heart Failure

    2001 · 301 citations
  3. Structure−Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors

    1997 · 142 citations
  4. 2-Substituted Aminopyrido[2,3-d]pyrimidin-7(8H)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity

    1998 · 130 citations
  5. Structure−Activity Relationships and Pharmacokinetic Analysis for a Series of Potent, Systemically Available Biphenylsulfonamide Matrix Metalloproteinase Inhibitors

    2000 · 100 citations
  6. In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor

    1997 · 96 citations
  7. Synthesis and Pharmacology of Benzoxazines as Highly Selective Antagonists at M4Muscarinic Receptors

    2002 · 85 citations
  8. Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8H-pyrido[2,3-d]pyrimidines: Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors

    1998 · 83 citations
  9. Hypercholesterolemia Causes Mechanical Weakening of Rabbit Atheroma

    2000 · 82 citations
  10. Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study

    2017 · 79 citations
  11. Endothelin Receptor Antagonist Increases Cerebral Perfusion and Reduces Ischaemic Damage in Feline Focal Cerebral Ischaemia

    1996 · 79 citations
  12. Prevention of subarachnoid hemorrhage—induced cerebral vasospasm by oral administration of endothelin receptor antagonists

    1996 · 68 citations
  13. Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery

    2003 · 59 citations
  14. Angiotensin-Converting Enzyme and Matrix Metalloproteinase Inhibition with Developing Heart Failure: Comparative Effects on Left Ventricular Function and Geometry

    1999 · 59 citations
  15. Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

    2016 · 58 citations
  16. Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

    2015 · 51 citations
  17. Societal perspectives on community pharmacy services in West Bank-Palestine

    2012 · 50 citations
  18. Prevalence, awareness, treatment and control of hypertension in the Palestinian population

    2013 · 49 citations
  19. Structure−Activity Relationships in a Series of Orally Active γ-Hydroxy Butenolide Endothelin Antagonists

    1997 · 46 citations
  20. Research Article: Computer‐Assisted Design of Pro‐drugs for Antimalarial Atovaquone

    2010 · 42 citations
  21. Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence

    2016 · 41 citations
  22. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine

    2011 · 41 citations
  23. Determination of hydroxyproline in plasma and tissue using electrospray mass spectrometry

    2003 · 39 citations
  24. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow

    1999 · 35 citations
  25. Computer-assisted design for atenolol prodrugs for the use in aqueous formulations

    2011 · 32 citations

← Return to the university profile